HomeACE • STO
add
Ascelia Pharma AB
Previous close
kr 3.03
Day range
kr 3.07 - kr 3.19
Year range
kr 2.00 - kr 17.98
Market cap
304.66M SEK
Avg Volume
758.37K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 22.29M | 91.90% |
Net income | -28.33M | -167.31% |
Net profit margin | — | — |
Earnings per share | -0.29 | 6.45% |
EBITDA | -22.27M | -92.04% |
Effective tax rate | 0.14% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 75.26M | 244.34% |
Total assets | 140.92M | 61.84% |
Total liabilities | 61.98M | 386.32% |
Total equity | 78.94M | — |
Shares outstanding | 96.11M | — |
Price to book | 3.70 | — |
Return on assets | -36.86% | — |
Return on capital | -46.72% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -28.33M | -167.31% |
Cash from operations | -18.78M | -17.94% |
Cash from investing | — | — |
Cash from financing | -1.98M | -797.73% |
Net change in cash | -20.46M | -19.40% |
Free cash flow | -4.02M | 69.52% |
About
Founded
1999
Website
Employees
11
